US Patent Issued to Accuredit Therapeutics (Suzhou) on May 27 for "Deaminases and variants thereof for use in base editing" (Chinese, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,619, issued on May 27, was assigned to Accuredit Therapeutics (Suzhou) Co. Ltd..

"Deaminases and variants thereof for use in base editing" was invented by Feifei Duan (Jiangsu, China), Songyuan Li (Jiangsu, China), Huanle Liu (Jiangsu, China), Fuxin Shi (Winchester, Mass.), Ke Qin (Jiangsu, China), Jialin Tao (Jiangsu, China), Pengfei Hu (Jiangsu, China) and Han Qiu (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are adenosine deaminases and variants thereof, nucleobase editors comprising deaminases, compositions comprising such editors, and methods of using such editors to generate modifications in target nucleobase s...